www.411mania.com
|  News |  Columns |  Reports |  Video Reviews |  Title History |  News Report |
SPOTLIGHTS  SPOTLIGHTS
MOVIES/TV
// Carla Howe Instagram a Series of Cleavage-Filled Swimsuit Selfies
MUSIC
// Fozzy - Do You Want to Start a War Review
WRESTLING
// 411's WWE RAW Report 7.21.14
MMA
// Arianny Celeste Hits The Beach in Booty-Baring Bikini on Instagram
GAMES
// Naughty Dog Considering Sequel Ideas For The Last Of Us


SYNDICATE  SYNDICATE



411mania RSS Feeds





Follow 411mania on Twitter!




Add 411 On Facebook
 


 
 411mania » MMA » News

Advertisement
Jessica Eye’s UFC 166 Victory Overturned Due to Positive Drug Test
Posted by Larry Csonka on 02.03.2014



According to mmajunkie.com, Jessica Eye's split decision win over Sarah Kaufman at UFC 166 in Houston being changed to a no-decision. This news comes from the Texas Department of Licensing and Regulation. It was revealed January 22nd that Eye "tested positive for a prohibited drug," and was fined $1,875 and placed on a "one year fully probated suspension."

Susan Stanford of the Texas Department of Licensing and Regulation has stated that Eye is effectively "on probation as long as she complies" with the administrative order, and can still fight in the interim. Eye says she will dispute the findings, insisting she is "not suspended at all" and will still fight Alexis Davis (15-5 MMA, 2-0 UFC) at UFC 170 on February 22nd.

Sarah Kaufman offered the following comments on the situation…

"It's not a loss but also not a win. I hate to see our sport marred by athletes who can't seem to control what substances they put in their bodies. It's disrespectful to their opponents and employers."





MUST-READ 411 STORIES:

Top 8 Scarlett Johansson Roles

Review of New Fozzy Album

New Carla Howe Lingerie Selfies


comments powered by Disqus







www.41mania.com
Copyright (c) 2011 411mania.com, LLC. All rights reserved.
Click here for our privacy policy. Please help us serve you better, fill out our survey.
Use of this site signifies your agreement to our terms of use.